Position in NVCT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$1,352,878
+$784,213 QoQ
Shares Held
73,566
0.0% QoQ
Ownership
0.226%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#20
of 82 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OPPENHEIMER & CO INC holds $50,552,262 across 50 Biotechnology names. NVCT ranks #11 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
22,129 | $13,798,316 | |
| 2 | VKTX |
Viking Therapeutics, Inc.
|
146,259 | $5,705,563 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
15,400 | $2,884,112 | |
| 4 | TYRA |
Tyra Biosciences, Inc.
|
83,783 | $2,676,029 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,250 | $2,111,102 | |
| 6 | TRVI |
Trevi Therapeutics, Inc.
|
99,771 | $1,860,729 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
75,714 | $1,823,193 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
107,453 | $1,818,104 |
All Filings in NVCT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,352,878 | 73,566 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $568,665 | 73,566 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $555,423 | 73,566 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $415,777 | 69,066 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $515,923 | 69,066 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $400,570 | 41,000 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $135,250 | 25,000 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||